GRAIL, LLC (GRAL) - Total Assets

Latest as of March 2026: $2.80 Billion USD

Based on the latest financial reports, GRAIL, LLC (GRAL) holds total assets worth $2.80 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore GRAIL, LLC (GRAL) cash conversion ratio to assess how effectively this company generates cash.

GRAIL, LLC - Total Assets Trend (2018–2025)

This chart illustrates how GRAIL, LLC's total assets have evolved over time, based on quarterly financial data. See GRAIL, LLC net assets for net asset value and shareholders' equity analysis.

GRAIL, LLC - Asset Composition Analysis

Current Asset Composition (December 2025)

GRAIL, LLC's total assets of $2.80 Billion consist of 32.6% current assets and 67.4% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 8.6%
Accounts Receivable $18.30 Million 0.6%
Inventory $16.02 Million 0.6%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $1.85 Billion 63.3%
Goodwill $0.00 0.0%

Asset Composition Trend (2018–2025)

This chart illustrates how GRAIL, LLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see GRAL market cap.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: GRAIL, LLC's current assets represent 32.6% of total assets in 2025, a decrease from 94.5% in 2018.
  • Cash Position: Cash and equivalents constituted 8.6% of total assets in 2025, down from 13.9% in 2018.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 63.0% of total assets, an increase from 0.0% in 2018.
  • Asset Diversification: The largest asset category is intangible assets at 63.3% of total assets.

GRAIL, LLC Competitors by Total Assets

Key competitors of GRAIL, LLC based on total assets are shown below.

Company Country Total Assets
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
China CN¥9.20 Billion
SMO ClinPlus Co. Ltd.
SHE:301257
China CN¥1.52 Billion
Healius Ltd
AU:HLS
Australia AU$1.77 Billion
RHYTHM Biosciences Ltd
AU:RHY
Australia AU$3.10 Million
Check-Cap Ltd.
NASDAQ:MBAI
USA $7.49 Million
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million

GRAIL, LLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 11.74 9.71 10.53
Quick Ratio 11.51 9.46 10.53
Cash Ratio 0.00 0.00 0.00
Working Capital $802.64 Million $652.68 Million $578.37 Million

GRAIL, LLC - Advanced Valuation Insights

This section examines the relationship between GRAIL, LLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.06
Latest Market Cap to Assets Ratio 0.91
Asset Growth Rate (YoY) -2.1%
Total Assets $2.92 Billion
Market Capitalization $2.65 Billion USD

Valuation Analysis

Near Book Valuation: The market values GRAIL, LLC's assets close to their book value (0.91x), suggesting investors view the company's assets at approximately fair value.

Slight Asset Contraction: GRAIL, LLC's assets decreased by 2.1% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for GRAIL, LLC (2018–2025)

The table below shows the annual total assets of GRAIL, LLC from 2018 to 2025.

Year Total Assets Change
2025-12-31 $2.92 Billion -2.05%
2024-12-31 $2.98 Billion -34.53%
2023-12-31 $4.56 Billion -18.66%
2022-12-31 $5.60 Billion -42.47%
2021-12-31 $9.74 Billion +1278.73%
2020-12-31 $706.30 Million +11.14%
2019-12-31 $635.52 Million -7.47%
2018-12-31 $686.85 Million --

About GRAIL, LLC

NASDAQ:GRAL USA Diagnostics & Research
Market Cap
$3.07 Billion
Market Cap Rank
#5430 Global
#1727 in USA
Share Price
$71.42
Change (1 day)
+3.57%
52-Week Range
$31.42 - $116.06
All Time High
$116.06
About

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides deve… Read more